CORDIS · 242244 · FP7
CHANCES Consortium on Health and Ageing: Network of Cohorts in Europe and the United States
Coordinator: HELLENIC HEALTH FOUNDATION (EL)
CHANCES aims at combining and integrating on-going cohort studies in order to produce evidence on ageing-related health characteristics and determinants in Europe, and their socio-economic implications. 15 cohorts participate, covering populations from 18 EU Member States, 4 associate countries, and 3 additional countries. The combination of these different studies would lead to an integrated approach to the study of health in the elderly. CHANCES will address 5 main types of health related characteristics: (i) incidence of chronic conditions, disabilities and mortality; (ii) prevalence of ch…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €11.9M awarded to the consortium. The project runs over approximately 5 years from 2010-02-01 to 2015-01-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from EL
see all →- Theseus — A First of a kind Hub for circularity demonstrator for Attica and peripheral regions101178059 · HORIZON · €20.0M
- COMFORTAGE — Prediction, Monitoring and Personalized Recommendations for Prevention and Relief of Dementia and Frailty101137301 · HORIZON · €17.6M
- Flex2Energy — Automated Manufacturing Production Line for Integrated Printed Organic Photovoltaics101096803 · HORIZON · €15.7M
- HERON — HERON Center of Excellence in Robotics101136568 · HORIZON · €15.0M
- SEAMLESS — Safe, Efficient and Autonomous: Multimodal Library of European Shortsea and inland Solutions101096923 · HORIZON · €15.0M
- FIDAL — Field Trials beyond 5G101096146 · HORIZON · €15.0M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-IP funding scheme.
- What is the EU contribution?
- The European Commission contributes €11.9M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by HELLENIC HEALTH FOUNDATION (EL).
- What is the project timeline?
- The project runs from 2010-02-01 to 2015-01-31 — approximately 5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 242244.